Skip to content
Home
News
About Us
Mission & Vision
Message from the CEO
Company Profile
Members
Access
Science & Technology
What Are Diabetes Stem Cells?
Complete Remission of Diabetes.
What Is Biozipcode™?
Cell-Targeting Technology
Academic Collaboration Overview
Dep. of Biocommunication Development (Kyoto Univ)
Domestic & Inter. Research Collaborations
Pipeline Overview
Diabetes Remission Therapy Candidate
Diabetes Stem Cell Biomarker
Biozipcode™ Cell-Targeted Diabetes Therapy
Cell-Targeted Oncology Therapeutics
Cell-Targeted Tissue Regeneration
Research Achievements
Selected Publications
Patents & Intellectual Property
Videos, Lectures & Presentations
For Partners
For Pharmaceutical Com. & Research Instit.
Research Collaboration
Technology Licensing
Co-development
Investment & Strategic Partnerships
Downloads
Contact
Contact Form
Legal & Policies
Privacy Policy
Website Policy
Cookie Policy
Medical & Scientific Disclaimer
Conflict of Interest & Transparency Policy
Japanese
Japanese
News
News
カテゴリ
ニュース
未分類
研究・開発
見出し
関連する記事
News
Announcement of a Seminar by Hideto Kojima, Head of Research and Development at Biozipcode, Inc. — “Say Goodbye to Diabetes!”
October 14, 2026
News
Biozipcode, Inc. Announces Acquisition of Rights Related to International Patent Applications for Diabetes Treatments
October 14, 2026
News
Launch of the Biozipcode, Inc. Website
October 14, 2026
Page load link
Go to Top